MG
MRNA icon

Michael Gelband’s Moderna MRNA Stock Holding History

Michael Gelband’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,099
Closed -$665K – 1883
2026
Q1 		$665K Sell
13,099
-25,606
-66% -$1.19M 0.01% 1114
2025
Q4 		$1.14M Sell
38,705
-175,000
-82% -$4.75M 0.01% 945
2025
Q3 		$5.52M Buy
+213,705
New +$5.96M 0.06% 372
2025
Q2 		– Sell
-16,771
Closed -$475K – 1788
2025
Q1 		$475K Sell
16,771
-71,199
-81% -$2.53M ﹤0.01% 1120
2024
Q4 		$3.66M Buy
+87,970
New +$4.2M 0.03% 532
2023
Q1 		– Sell
-4,293
Closed -$771K – 1994
2022
Q4 		$771K Sell
4,293
-4,615
-52% -$755K 0.01% 1031
2022
Q3 		$1.05M Buy
+8,908
New +$1.35M 0.01% 1086
2022
Q1 		– Sell
-3,451
Closed -$876K – 2510
2021
Q4 		$876K Sell
3,451
-74
-2% -$21.6K 0.01% 1148
2021
Q3 		$1.36M Sell
3,525
-332,981
-99% -$123M 0.02% 891
2021
Q2 		$79.1M Buy
336,506
+301,520
+862% +$53.9M 0.87% 8
2021
Q1 		$4.58M Sell
34,986
-30,257
-46% -$4.38M 0.07% 306
2020
Q4 		$6.82M Buy
65,243
+56,469
+644% +$5.71M 0.07% 186
2020
Q3 		$621K Sell
8,774
-7,618
-46% -$531K 0.01% 903
2020
Q2 		$1.05M Sell
16,392
-14,413
-47% -$789K 0.03% 718
2020
Q1 		$923K Buy
+30,805
New +$709K 0.05% 326

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Michael Gelband's MRNA Position: Q2 2026 in Review

Michael Gelband sold out of Moderna (MRNA) in Q2 2026, closing a stake of 13,099 shares — an estimated $665K sold.

Michael Gelband first reported a position in MRNA in Q1 2020 and held it in 15 quarters. The position peaked at $79.1M in Q2 2021. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Michael Gelband reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 13,099 Moderna shares in Q2 2026, an estimated $665K.
  • Michael Gelband first reported a position in Moderna in Q1 2020 and held it in 15 quarters.
  • Michael Gelband's Moderna position peaked at $79.1M in Q2 2021.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.